Industry and Academic Pros Attract More Than 150 Participants at Aptuit, Inc. Science Day in Verona, Italy
Published: Aug 24, 2012
Aptuit hosted the free event which focused on “Challenging Current Paradigms in Early Drug Development.”
“For the event, we engaged prominent and highly respected scientists, knowledgeable in early drug development, to deliver presentations during our full day’s agenda. Several of the speakers spoke of recent and innovative approaches that reduce the time, costs and attrition of drug development – the issues that are at the heart of our common concerns and interests,” said Mark Hembarsky, Vice President and Site Director at Verona.
Last year Aptuit initiated the Aptuit Scientific Symposium at their Verona, Italy location. From this site, Aptuit offers a fully integrated offering of drug discovery and development services.
Referring to the 2011 Science Day, Mr. Needleman concluded, “Since the May 16, 2012 event repeated last year’s great success, we are looking forward to another Aptuit hosted symposium of its kind. Those who attended found it a valuable experience, and it provided the opportunity for our guests to have a firsthand encounter with Aptuit people with heads for science and hearts for service.”
Details about the Science Day, including copies of the presentations, are available at the Aptuit Verona microsite: www.aptuit.com/Verona.
For press information, please contact Maria Garvey at Delfino Marketing either by phone at 914-747-1400 or by email: firstname.lastname@example.org.
Aptuit is a global pharmaceutical services company focusing on delivering contract development and manufacturing services and streamlining the drug development process for biotechnology and pharmaceutical innovators. Aptuit’s employees deliver an integrated suite of product development services to more than 800 companies worldwide driven by a deep commitment to client service, quality and an unrivalled track record of scientific excellence. The company is partnered with Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information about Aptuit, visit www.aptuit.com